Regulatory Processes for Rare Disease Drugs in the United States and European Union

Flexibilities and Collaborative Opportunities

Regulatory Processes for Rare Disease Drugs in the United States and European Union voorzijde
Regulatory Processes for Rare Disease Drugs in the United States and European Union achterzijde
  • Regulatory Processes for Rare Disease Drugs in the United States and European Union voorkant
  • Regulatory Processes for Rare Disease Drugs in the United States and European Union achterkant

Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe.

Specificaties
ISBN/EAN 9780309726559
Auteur Engineering National Academies of Sciences
Uitgever Van Ditmar Boekenimport B.V.
Taal Engels
Uitvoering Paperback / gebrocheerd
Pagina's 386
Lengte
Breedte

Wat vinden anderen?

Er zijn nog geen reviews van dit product.